SignalCorporate
Merck (MRK) Surpasses Q3 Earnings and Revenue Estimates
Merck beat Q3 earnings and revenue estimates.
Context
What happened: Merck ($MRK) reported quarterly adjusted earnings of $2.49 per share and revenue of $18.09 billion, beating the Zacks Consensus Estimate for both.
Key numbers: EPS $2.49 vs. estimate $2.12, a +17.45% surprise, versus $2.58 a year ago.
Why it matters: Estimate revisions trend was unfavorable ahead of the release, translating into a Zacks Rank #5 (Strong Sell), and the shares are expected to underperform the market in the near future. The Large Cap Pharmaceuticals industry is in the bottom 11% of Zacks-ranked industries.
Market: -0.6% today ($140.93), +33.4% YTD, 0.8x vol — as of 12:15 UTC
Verified: Q3_2026 (Oct 29) revenue $17.3B vs $17.3B est; next print ~Jan 28
Coverage: 5 outlets in 24h
What changed
Merck ($MRK) reported quarterly adjusted earnings of $2.49 per share and revenue of $18.09 billion, beating the Zacks Consensus Estimate for both.
Why it matters
Estimate revisions trend was unfavorable ahead of the release, translating into a Zacks Rank #5 (Strong Sell), and the shares are expected to underperform the market in the near future. The Large Cap Pharmaceuticals industry is in the bottom 11% of Zacks-ranked industries.
Market: -0.6% today ($140.93), +33.4% YTD, 0.8x vol — as of 12:15 UTC
Verified: Q3_2026 (Oct 29) revenue $17.3B vs $17.3B est; next print ~Jan 28